Page last updated: 2024-08-23

piperacillin and Obesity

piperacillin has been researched along with Obesity in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's7 (87.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheatham, SC; Chung, EK; Fleming, MR; Healy, DP; Kays, MB; Shea, KM1
Abdul-Aziz, MH; Alobaid, AS; Brinkmann, A; Frey, OR; Grau, S; Lipman, J; Luque, S; Roberts, JA; Roberts, MS; Roehr, AC; Wong, G1
Breilh, D; Jaber, S; Jean-Pierre, H; Jung, B; Legeron, R; Mahul, M; Molinari, N; Signe, J; Uhlemann, AC1
Batista, N; Fernández, MP; Gambra, ML; Rodríguez, L1
Jahagirdar, R; Khadilkar, AV; Khadilkar, VV; Lalwani, S; Rustagi, VT1
Deman, H; Spriet, I; Verhaegen, J; Willems, L1
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F1
Cheatham, SC; Chung, CE; Fleming, MR; Healy, DP; Humphrey, ML; Kays, MB; Shea, KM1

Trials

1 trial(s) available for piperacillin and Obesity

ArticleYear
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Body Weight; Computer Simulation; Creatinine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Monte Carlo Method; Obesity; Penicillanic Acid; Piperacillin; Tazobactam

2015

Other Studies

7 other study(ies) available for piperacillin and Obesity

ArticleYear
What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Critical Illness; Female; Germany; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Obesity; Piperacillin; Plasma; Pseudomonas aeruginosa; Retrospective Studies; Spain; Thienamycins; Young Adult

2016
Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.
    Critical care medicine, 2017, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Mass Index; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Shock, Septic

2017
[Fournier's gangrene caused by Streptococcus agalactiae in a non-pregnant woman].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clindamycin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Female; Fournier Gangrene; Humans; Metronidazole; Obesity; Penicillanic Acid; Perineum; Piperacillin; Reoperation; Streptococcal Infections; Streptococcus agalactiae; Tazobactam

2009
Right atrial thrombus in a six- year- old Indian boy with metabolic syndrome.
    Journal of pediatric endocrinology & metabolism : JPEM, 2010, Volume: 23, Issue:6

    Topics: Acanthosis Nigricans; Anti-Bacterial Agents; Anticoagulants; Child; Drug Therapy, Combination; Echocardiography, Doppler; Heart Atria; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Male; Metabolic Syndrome; Obesity; Penicillanic Acid; Piperacillin; Positive-Pressure Respiration; Tazobactam; Thrombosis; Treatment Outcome; Warfarin

2010
Dosing of piperacillin/tazobactam in a morbidly obese patient.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Male; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Serum

2012
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult

2013
Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Blood Chemical Analysis; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors

2013